Arcutis Biotherapeutics Inc (ARQT) USD0.0001

Sell:$13.01Buy:$13.02$0.40 (2.98%)

NASDAQ:2.20%
Market closed | Prices delayed by at least 15 minutes
Sell:$13.01
Buy:$13.02
Change:$0.40 (2.98%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$13.01
Buy:$13.02
Change:$0.40 (2.98%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Arcutis Biotherapeutics, Inc. is a commercial-stage medical dermatology company. The Company is focused on developing and commercializing treatments for dermatological diseases with high-unmet medical needs. Its portfolio is comprised of topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. Its lead product, ZORYVE, is for the treatment of plaque psoriasis, including psoriasis in the intertriginous areas, in individuals 12 years of age or older. ZORYVE cream is a once-daily topical formulation of roflumilast, a potent and selective phosphodiesterase-4 (PDE4) inhibitor. The Company’s pipeline includes ARQ-255, ARQ-252, and ARQ-234. ARQ-255 is developed for alopecia areata. ARQ-252 is an alternative topical cream formulation of ivarmacitinib that the Company is developing for chronic hand eczema and vitiligo. ARQ-255 is developed for the treatment of alopecia areata.

Key people

Todd Franklin Watanabe
President, Chief Executive Officer, Director
David Topper
Chief Financial Officer, Senior Vice President
Patrick E. Burnett
Executive Vice President, Chief Medical Officer
L. Todd Edwards
Executive Vice President, Chief Commercial Officer
Masaru Matsuda
Senior Vice President, General Counsel
Matthew R. Moore
Senior Vice President, Chief Business Officer
Kent Taylor
Vice President of Sales
Patrick J. Heron
Independent Chairman of the Board
Bhaskar Chaudhuri
Independent Director
Terrie J. Curran
Independent Director
Halley E. Gilbert
Independent Director
Neha Krishnamohan
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US03969K1088
  • Market cap
    $1.52bn
  • Employees
    296
  • Shares in issue
    117.04m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.